2-chloroadenosine has been researched along with cladribine in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (11.54) | 18.7374 |
1990's | 37 (71.15) | 18.2507 |
2000's | 7 (13.46) | 29.6817 |
2010's | 2 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clayton, SD; Montgomery, JA; Riordan, JM; Secrist, JA; Shortnacy-Fowler, AT | 1 |
Cristalli, G; Esker, JL; Jacobson, KA; Ji, XD; Melman, N; Olah, ME; Schneller, SW; Secrist, JA; Siddiqi, SM; Tiwari, KN | 1 |
Barbieri, D; Camaioni, E; Costanzi, S; Cristalli, G; Franceschi, C; Vittori, S; Volpini, R | 1 |
Abdelrahman, A; Alksnis, E; Borrmann, T; Cristalli, G; Gorzalka, S; Knospe, M; Lambertucci, C; Müller, CE; Schiedel, AC; Volpini, R | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Huang, Y; Li, J; Luo, HB; Mao, F; Qiu, X; Wu, D; Yan, W; Zhu, J | 1 |
Piro, LD | 1 |
Beran, M; Estey, EH; Hirsch-Ginsberg, C; Huh, YO; Kantarjian, HM; Keating, MJ; Koller, C; Kurzrock, R; McCredie, KB; O'Brien, SM | 1 |
Juliusson, G; Liliemark, J | 3 |
Cheson, BD | 3 |
Blakley, RL; Crom, W; Kearns, C; Mirro, J; Santana, VM; Schell, MJ | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Kay, AC; Piro, LD; Saven, A; Thurston, D | 1 |
Hagberg, H | 1 |
Carrera, CJ; Carson, DA; Cottam, HB; Esparza, LM; Kipps, TJ; Wasson, DB | 1 |
Nightingale, SL | 1 |
Daly, K; Golomb, HM; Mick, R; Ratain, MJ | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A | 1 |
Alexanian, R; Dimopoulos, MA; Estey, EH; Kantarjian, HM | 1 |
Elmhorn-Rosenborg, A; Juliusson, G; Liliemark, J | 1 |
Belt, J; Brenner, MK; Crom, W; Hurwitz, CA; Krance, R; Mahmoud, H; Ribeirio, R; Roberts, WM; Santana, VM; Schell, MJ | 1 |
Arizono, K; Brady, FO; Garrett, SH; Xiong, X | 1 |
Blakley, RL; Cherrie, J; Harwood, FC; Kalwinsky, D; Mirro, J; Santana, VM; Schell, M | 1 |
Plunkett, W; Saunders, PP | 1 |
Gribbin, TE | 1 |
Hiraoka, W; Kuwabara, M; Matsuda, A; Sato, F; Tamura, Y; Tanabe, K; Ueda, T | 1 |
Juliusson, G; Liliemark, J; Pettersson, B | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A; Terai, C | 1 |
Blatt, LM; Ozes, ON; Reiter, Z; Taylor, MW; Tomson, S | 1 |
Bilgeri, R; Braunsteiner, H; Geisen, FH; Haun, M; Konwalinka, G; Petzer, AL; Pragnell, I; Zilian, U | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Curd, JG; Lotz, M; Piro, LD; Terai, C | 1 |
Golde, DW; Lill, MC | 1 |
Gutterman, JU; Kurzrock, R; Talpaz, M | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD | 1 |
Belt, JA; Crawford, CR; Ng, CY | 1 |
Blakley, RL; Griffig, J; Koob, R | 1 |
Hiraoka, W; Kuwabara, M; Matsuda, A; Sato, F; Tanabe, K; Ueda, T | 1 |
Hiramoto-Yoshioka, A; Watanabe, K; Wataya, Y; Yoshida, S | 1 |
Carrera, CJ; Carson, DA; Lotz, M; Piro, LD; Yamanaka, H | 1 |
Hiramoto-Yoshioka, A; Hirota, Y; Matsuda, A; Minowada, J; Otani, T; Tanaka, S; Ueda, T; Wataya, Y | 1 |
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Wasson, DB | 1 |
Szondy, Z | 1 |
Bloński, JZ; Ceglarek, B; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Grieb, P; Hansz, J; Hellmann, A; Holowiecki, J; Kasznicki, M; Komarnicki, M; Konopka, L; Kroll, R; Kuliczkowski, K; Lewandowski, K; Nowak, W; Potoczek, S; Robak, T; Skotnicki, AB; Soroka-Wojtaszko, M; Tomaszewska, A; Zdziarska, B | 1 |
Abbracchio, MP; Ambrosini, A; Barbieri, D; Camurri, A; Cattabeni, F; Ceruti, S; Franceschi, C; Giammarioli, AM; Malorni, W; Racagni, G | 1 |
Abdel-Hamid, M; Hamza, H; Novotny, L | 1 |
Abbracchio, MP; Beltrami, E; Cattabeni, F; Ceruti, S; Malorni, W; Matarrese, P; Mazzola, A | 1 |
Liang, NC; Liu, XG; Zhu, F | 1 |
Bellezza, I; Conte, C; Culig, Z; Minelli, A; Rambotti, MG; Tucci, A | 1 |
6 review(s) available for 2-chloroadenosine and cladribine
Article | Year |
---|---|
The treatment of hairy cell leukemia: an update.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy | 1992 |
Metabolism and action of purine nucleoside analogs.
Topics: 2-Chloroadenosine; Adenosine; Cladribine; Deoxyadenosines; Guanine; Guanosine; Humans; Purine Nucleosides; Ribavirin; Vidarabine | 1991 |
New purine analogues for the treatment of chronic B-cell malignancies.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Vidarabine | 1991 |
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
Hairy cell leukaemia: review of treatment.
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Granulocyte Colony-Stimulating Factor; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy | 1991 |
Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Topics: 2-Chloroadenosine; Adenosine Deaminase; Anemia, Hemolytic, Autoimmune; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell | 1989 |
7 trial(s) available for 2-chloroadenosine and cladribine
Article | Year |
---|---|
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Deoxyadenosines; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1992 |
2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bacterial Infections; Bone Marrow Diseases; Cladribine; Deoxyadenosines; Drug Evaluation; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Treatment Outcome | 1992 |
Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Topics: 2-Chloroadenosine; Adult; Antineoplastic Agents; Cladribine; Deoxyadenosines; Drug Resistance; Female; Haptoglobins; Humans; Immunoglobulins; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphocytes; Male; Middle Aged; Remission Induction; Vidarabine | 1992 |
Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Cladribine; Cytarabine; Daunorubicin; Deoxyadenosines; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Remission Induction | 1992 |
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Topics: 2-Chloroadenosine; Adolescent; Adult; Child; Child, Preschool; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxyadenosines; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis | 2000 |
40 other study(ies) available for 2-chloroadenosine and cladribine
Article | Year |
---|---|
Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
Topics: Animals; Antimetabolites, Antineoplastic; Escherichia coli; HIV; Humans; Leukemia P388; Mice; Purine-Nucleoside Phosphorylase; Structure-Activity Relationship; Tumor Cells, Cultured; Vidarabine | 1992 |
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
Topics: Adenosine; Animals; Cell Membrane; CHO Cells; Corpus Striatum; Cricetinae; In Vitro Techniques; Magnetic Resonance Spectroscopy; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Rats; Recombinant Proteins; Ribose; Structure-Activity Relationship | 1995 |
Modulation of apoptosis in human lymphocytes by adenosine analogues.
Topics: 2-Chloroadenosine; Apoptosis; Cells, Cultured; Deoxyadenosines; Flow Cytometry; Humans; Lymphocytes; Models, Chemical; Propidium; Structure-Activity Relationship | 1998 |
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
Topics: Adenine; Animals; Astrocytoma; Cell Line; Cell Line, Tumor; Cerebral Cortex; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Tubercidin | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation.
Topics: Cyclic Nucleotide Phosphodiesterases, Type 2; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Molecular Structure; Nucleosides; Phosphodiesterase Inhibitors; Purines; Structure-Activity Relationship | 2018 |
2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Lymphoma | 1992 |
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Drug Resistance; Humans; Leukemia, Hairy Cell; Leukocyte Count; Leukopenia; Male; Middle Aged; Neutrophils; Platelet Count; Remission Induction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1992 |
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia | 1992 |
The purine analogs--a therapeutic beauty contest.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1992 |
[Alpha interferon treatment in hairy cell leukemia].
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin | 1992 |
Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Topics: 2-Chloroadenosine; Adenine Nucleotides; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Cell Death; Cladribine; Clofarabine; Deoxyadenosines; DNA; DNA Damage; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Mice; Mice, SCID; Monocytes | 1992 |
The purine analogs--a therapeutic beauty contest.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Pentostatin; Vidarabine | 1992 |
From the Food and Drug Administration.
Topics: 2-Chloroadenosine; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Antitubercular Agents; Cladribine; Deoxyadenosines; Drugs, Investigational; Equipment and Supplies; Fetus; Humans; Leukemia, Hairy Cell; Mycobacterium avium-intracellulare Infection; Product Surveillance, Postmarketing; Rifabutin; Rifamycins; United States; United States Food and Drug Administration | 1992 |
Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Neoplasms | 1992 |
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors | 1992 |
Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1992 |
2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
Topics: 2-Chloroadenosine; Adult; Aged; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Humans; Male; Middle Aged; Multiple Myeloma | 1992 |
Purinergic agonist induction of metallothionein.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cells, Cultured; Cladribine; Deoxyadenosines; Dose-Response Relationship, Drug; Immunoblotting; Liver; Male; Metallothionein; Rats; Rats, Inbred Strains; RNA, Messenger; Theophylline; Time Factors; Transcription, Genetic; Vasodilator Agents | 1992 |
[A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Lymphoproliferative Disorders | 1991 |
On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans.
Topics: 2-Chloroadenosine; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; Humans; Leukemia | 1991 |
2-Chlorodeoxyadenosine inhibits the repair of DNA double-strand breaks and does not inhibit the repair of DNA single-strand breaks in X-irradiated Chinese hamster V79 cells.
Topics: 2-Chloroadenosine; Animals; Cell Line; Cell Survival; Cladribine; Cricetinae; Cricetulus; Deoxyadenosines; DNA; DNA Damage; DNA Repair; DNA, Single-Stranded; Dose-Response Relationship, Drug; X-Rays | 1991 |
Determination of 2-chloro-2'-deoxyadenosine in human plasma.
Topics: 2-Chloroadenosine; Aged; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; Humans; Lymphoma, T-Cell, Cutaneous; Male | 1991 |
2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
Topics: 2-Chloroadenosine; Cell Death; Cladribine; Deoxyadenosines; DNA; DNA Damage; Humans; In Vitro Techniques; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Nucleosomes; Reference Values | 1991 |
A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Topics: 2-Chloroadenosine; Acquired Immunodeficiency Syndrome; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Cladribine; Cytotoxicity, Immunologic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluorouracil; Humans; Interferon Type I; Killer Cells, Natural; Kinetics; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recombinant Proteins; Sarcoma, Kaposi; Uterine Cervical Neoplasms | 1991 |
Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid, and T-lymphocytic colony growth.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cells, Cultured; Cladribine; Clone Cells; Colony-Forming Units Assay; Deoxyadenosines; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Granulocytes; Hematopoietic Stem Cells; Humans; T-Lymphocytes; Time Factors | 1991 |
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
Topics: 2-Chloroadenosine; Adenosine Triphosphate; Cell Survival; Cells, Cultured; Cladribine; Deoxyadenosines; DNA Damage; Humans; Interleukin-6; Lymphoma, T-Cell; Monocytes; Mutagens; NAD; Phagocytosis; Protein Biosynthesis; RNA; Time Factors | 1990 |
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Adult; Antineoplastic Agents; Bone Marrow; Cladribine; Deoxyadenosines; Female; Humans; Infusions, Parenteral; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction | 1990 |
Isolation and characterization of an L1210 cell line retaining the sodium-dependent carrier cif as its sole nucleoside transport activity.
Topics: 2-Chloroadenosine; Affinity Labels; Animals; Carrier Proteins; Cell Division; Cell Membrane; Cell Survival; Cladribine; Deoxyadenosines; Kinetics; Leukemia L1210; Membrane Transport Proteins; Methotrexate; Mice; Mutation; Nucleosides; Sodium; Thioinosine; Thymidine; Tumor Cells, Cultured | 1990 |
Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
Topics: 2-Chloroadenosine; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; DNA Replication; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Ribonucleotides; Tumor Cells, Cultured | 1989 |
Induction of DNA double-strand breaks in Chinese hamster V79 cells by 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Animals; Bucladesine; Cell Line; Cladribine; Cricetinae; Cricetulus; Cycloheximide; Deoxyadenosines; DNA; DNA Damage; Kinetics; Lung; Radioisotope Dilution Technique; Thymidine; Tritium | 1989 |
dNTP imbalance and DNA double strand breaks in mouse FM3A cells and the mechanism of cell death.
Topics: 2-Chloroadenosine; Animals; Cell Survival; Cladribine; Deoxyadenosines; Deoxyribonucleotides; DNA Damage; DNA, Neoplasm; Floxuridine; Mice; Tumor Cells, Cultured | 1989 |
Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; DNA Damage; Humans; In Vitro Techniques; Lymphoma; Monocytes; Pentostatin; T-Lymphocytes | 1989 |
The mechanism of 2-chlorodeoxyadenosine-induced cell death.
Topics: 2-Chloroadenosine; Cell Survival; Cladribine; Cycloheximide; Deoxyadenosines; Deoxycytidine; DNA Damage; Humans; Leukemia; Lymphoma; Tumor Cells, Cultured | 1989 |
The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine.
Topics: 2-Chloroadenosine; Apoptosis; Blotting, Western; Calcium; Cell Death; Cladribine; Dipyridamole; DNA Damage; Endonucleases; Humans; Infant; Protein Kinase C; Signal Transduction; Thymus Gland; Tumor Suppressor Protein p53 | 1995 |
Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance.
Topics: 2-Chloroadenosine; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Brain Neoplasms; Cell Adhesion; Cell Division; Cell Line; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Cladribine; Coloring Agents; Culture Media; Flow Cytometry; Humans; Mice; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Stability study of selected adenosine nucleosides using LC and LC/MS analyses.
Topics: 2-Chloroadenosine; Chromatography, Liquid; Cladribine; Drug Stability; Hydrolysis; Kinetics; Mass Spectrometry | 2000 |
A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Apoptosis; Astrocytoma; Caspase 2; Caspase 3; Caspase 8; Caspase 9; Caspases; Cladribine; Cytochrome c Group; Enzyme Activation; Humans; Mitochondria; Tumor Cells, Cultured | 2003 |
[nhibitory effect of adenosine analogues on invasion of human ovarian cancer cell line HO-8910PM].
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cladribine; Deoxyadenosines; Female; Histone Deacetylases; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Repressor Proteins; RNA, Messenger; Trans-Activators | 2004 |
Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Topics: 2-Chloroadenosine; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Cladribine; Disease Models, Animal; Glutathione; Humans; Male; Mice; NF-E2-Related Factor 2; Nucleoside Transport Proteins; Prostatic Neoplasms; Purinergic P1 Receptor Agonists; Reactive Oxygen Species | 2009 |